Roger Tsien dies; the CRISPR patent dispute you’ve never heard of; immunotherapy for Alzheimer’s; Tasmanian devils developing resistance to transmissible cancer

A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

What’s in store for commercialization grants at the Canadian Institutes of Health Research?

Celebrating lab techs; Myriad settles suits; publish in top-tier journals or perish

It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.

The importance of smORFs; America Invents Act and innovation in biotech; birds adjust their behavior to avoid cars; in defense of fundamental science

The America Invents Act (AIA) was a step in the right direction for US competitiveness and open innovation.

A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

Two lawsuits against prominent researcher Craig Thompson for allegedly failing to share intellectual property with his institution lead to a licensing agreement on cancer diagnostics.

Two key patent cases that no doubt will impact the future of personalized medicine are pending review by the US Supreme Court. What will the Court decide?

How to successfully surmount the challenges women face in becoming biotech industry leaders

A US federal appeals court says human genes are patentable.

To meet the agricultural demands of the growing population, appropriate technology transfer incentives are a must.

Legal battles over gene patents and uncooperative patent holders threaten the widespread implementation of personalized medicine.